MXCT

MaxCyte, Inc.

4.67 USD
+0.13 (+2.86%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

MaxCyte, Inc. stock is up 27.6% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 4 May’s closed higher than April.

About MaxCyte, Inc.

MaxCyte, Inc. engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.